CLINICAL ROLE -
EP. 1: Practice Pearl #1 Introduction, Definition and Diagnosis of Neuroendocrine Tumors
A panel of experts in neuroendocrine tumors provide a definition of the disease and the diagnosis methods.
Watch
EP. 2: Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
Megan May, PharmD, BCOP, and Daneng Li, MD, discuss when patients with NETs should be considered for active surveillance vs treatment.
EP. 3: Practice Pearl 1 How NETs Treatment Landscape Has Evolved
Experts in the management of NETs discuss how the treatment landscape has evolved.
EP. 4: Practice Pearl 2: Efficacy of the Somatostatin Analogues for NETs
Megan May, PharmD, BCOP, and Daneng Li, MD, review the efficacy and the pivotal trials for the somatostatin analogues in the treatment of NETs.
EP. 5: Practice Pearl 2: Indications and Safety Data of the Somatostatin Analogues for NETs
The panel of experts in the management of NETs review the indications and safety data of the somatostatin analogues.
EP. 6: Practice Pearl 2: Differences Among the Somatostatin Analogues for NETs
Cecilia Lau, RPh, BCOP, APh, and Daneng Li, MD, review the differences among the somatostatin analogues, particularly the differences in PK data.
EP. 7: Practice Pearl 2: Choosing 1 Agent Over Another in the Management of NETs
The panel of experts discuss how they choose 1 somatostatin analogue over another and the factors to consider in the management of NETs.
EP. 8: Practice Pearl 2: Pharmacists’ Role in Managing Treatment for Patient With NETs
Megan May, PharmD, BCOP, and Cecilia Lau, RPh, BCOP, APh, discuss the pharmacists’ role in choosing the treatment plan for patients with NETs.
EP. 9: Practice Pearl 2: Various Preparations and Delivery Systems of Somatostatin Analogues for NETs
Experts in the management of NETs review the various delivery systems and preparations available for short- and long-acting somatostatin analogues.
EP. 10: Practice Pearl 2: Home Injection Programs for the Treatment of NETs
Megan May, PharmD, BCOP, and Daneng Li, MD, discuss the availability of home-injection programs for patients with NETs, especially during the coronavirus pandemic.
EP. 11: Practice Pearl 2: Efficacy and Safety Data of Everolimus for NETs
Cecilia Lau, RPh, BCOP, APh, reviews the efficacy and safety data for everolimus in the treatment of NETs.
EP. 12: Practice Pearl 2: Management of Stomatitis When Using Everolimus for NETs
Cecilia Lau, RPh, BCOP, APh, and Daneng Li, MD, discuss the management of stomatitis caused by everolimus when used for NETs.
EP. 13: Practice Pearl 2: The Role of Peptide Receptor Radionuclide Therapy for NETs
A panel of experts in the management of NETs discuss the role of peptide receptor radionuclide therapy for NETs.
EP. 14: Practice Pearl 3: Challenges for Obtaining Therapeutic Agents on Formulary for NETs
Experts in the management of NETs share the challenges of getting therapeutic agents on the formulary.
EP. 15: Practice Pearl 3 Challenges in Obtaining Authorization for the Treatments for NETs
Megan May, PharmD, BCOP, reviews the authorization process for treatment options for the management of NETs.
EP. 16: Practice Pearl 3 Challenges in the Management Among the Various Sites of NETs
A panel of experts in neuroendocrine tumors review the challenges in the management of patients based on the site of the tumor.
EP. 17: Practice Pearl 3 Unmet Needs in the Treatment of Neuroendocrine Tumors
Megan May, PharmD, BCOP, Cecilia Lau, RPh, BCOP, APh, and Daneng Li, MD, share their thoughts on unmet needs in the management of neuroendocrine tumors.
